You have read all your free articles, to continue reading subscribe to read the rest of this content.
Antaros Medical, has entered into a research agreement with SANOFI. The project seeks to increase the understanding of the activity of certain incretins and underscores the vital role Antaros Medical plays as a trusted partner to major drug manufacturers. “The Antaros team has an impressive traAlready a subscriber Login You…
BioArctic's partner Eisai has announced results for the large global Phase 3 confirmatory Clarity AD study in 1,795 subjects. The study met the primary endpoint showing a highly statistically significant reduction of clinical decline. All key secondary endpoints were also met demonstrating highlyAlready a subscriber Login You have read all…
Hemab Therapeutics has announced the closing of an oversubscribed Series B financing. The round was led by Access Biotechnology with participation from new investors Deep Track Capital, Avoro Ventures, Invus, Rock Springs Capital, and Maj Invest Equity. All current investors including HealthCap, Already a subscriber Login You have read all…
Interest in developing drugs for orphan diseases is expected to grow into the next decade, leading to orphan drugs making up 19 percent of all prescription sales by 2020, according to some estimates. Sales also could increase at a rate of almost 11 percent per year through the end of…
